Cidara Therapeutics, Inc.
CDTXDelisted Jan 7, 2026- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001610618
Cidara Therapeutics, Inc. was delisted on Jan 7, 2026; its insiders filed their last Form 4 on Jan 9, 2026; 255 institutions reported holding it in 13F filings for Q4 2025, worth $7.36B in total; 3 superinvestors held it, including Maverick Capital and Soros Fund Management.
13F holders, Q4 2022
Institutional positions in Cidara Therapeutics, Inc. as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 42
- 0 vs. Q3 2022
- Shares held
- 26.6M
- −423.4K (−1.6%) vs. Q3 2022
- Total value
- $20.2M
- +$3.09M (+18.1%) vs. Q3 2022
- New holders
- 9
- 8 more added
- Sold out
- 9
- 8 more reduced
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CDTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 255 | $7.36B |
| Q3 2025 | 173 | $3.11B |
| Q2 2025 | 109 | $1.26B |
| Q1 2025 | 46 | $205.9M |
| Q4 2024 | 40 | $183.6M |
| Q3 2024 | 27 | $35.6M |
| Q2 2024 | 26 | $16.9M |
| Q1 2024 | 50 | $20.3M |
| Q4 2023 | 51 | $18.4M |
| Q3 2023 | 52 | $22.7M |
| Q2 2023 | 52 | $29.7M |
| Q1 2023 | 54 | $34.4M |
| Q4 2022 | 42 | $20.2M |
| Q3 2022 | 42 | $17.1M |
| Q2 2022 | 46 | $13.3M |
| Q1 2022 | 44 | $25.2M |
| Q4 2021 | 53 | $39.5M |
| Q3 2021 | 50 | $42.1M |
| Q2 2021 | 55 | $40.5M |
| Q1 2021 | 62 | $56.6M |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding Cidara Therapeutics, Inc.; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| BVF Inc | 6,861,127 | $5.19M | 0.22% | 00.0% | Unchanged |
| Nantahala Capital Management, LLC | 4,367,464 | $3.30M | 0.30% | −191,737−4.2% | Reduced |
| Point72 Asset Management, L.P. | 3,868,006 | $2.93M | 0.01% | 00.0% | Unchanged |
| Vanguard Group Inc | 2,469,150 | $1.87M | 0.00% | +1,2170.0% | Added |
| Alethea Capital Management, LLC | 1,677,194 | $1.27M | 1.22% | 00.0% | Unchanged |
| Acadian Asset Management LLC | 1,256,602 | $948.0K | 0.00% | +43,071+3.5% | Added |
| Renaissance Technologies LLC | 1,185,373 | $896.0K | 0.00% | −107,900−8.3% | Reduced |
| 5AM Venture Management, LLC | 1,134,511 | $858.0K | 0.23% | 00.0% | Unchanged |
| Millennium Management LLC | 689,917 | $522.0K | 0.00% | +606,201+724.1% | Added |
| Geode Capital Management, LLC | 592,724 | $448.0K | 0.00% | +7,743+1.3% | Added |
| West Family Investments, Inc. | 368,910 | $279.0K | 0.10% | 00.0% | Unchanged |
| Citadel Advisors LLC | 301,612 | $228.1K | 0.00% | +301,612 | New |
| US Bancorp | 262,072 | $198.2K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 230,937 | $174.7K | 0.00% | 00.0% | Unchanged |
| Artal Group S.A. | 224,675 | $170.0K | 0.01% | 00.0% | Unchanged |
| Jeppson Wealth Management, LLC | 160,610 | $121.5K | 0.05% | −13,565−7.8% | Reduced |
| Tocqueville Asset Management L.P. | 136,000 | $102.9K | 0.00% | +32,000+30.8% | Added |
| BlackRock Inc. | 132,466 | $100.2K | 0.00% | −64,143−32.6% | Reduced |
| Northern Trust Corp | 105,490 | $79.8K | 0.00% | 00.0% | Unchanged |
| Callan Capital, LLC | 103,462 | $78.2K | 0.01% | +103,462 | New |
| Raymond James Financial Services Advisors, Inc. | 73,655 | $55.7K | 0.00% | −15,031−16.9% | Reduced |
| Goldman Sachs Group Inc | 67,097 | $50.7K | 0.00% | −5,294−7.3% | Reduced |
| Jane Street Group, LLC | 62,482 | $47.3K | 0.00% | +62,482 | New |
| Prudential Financial Inc | 61,200 | $46.3K | 0.00% | +7,200+13.3% | Added |
| Money Concepts Capital Corp | 55,000 | $41.6K | 0.00% | +55,000 | New |
| Aveo Capital Partners, LLC | 42,502 | $32.1K | 0.00% | 00.0% | Unchanged |
| Level Four Advisory Services, LLC | 27,927 | $21.1K | 0.00% | +27,927 | New |
| Two Sigma Advisers, LP | 25,800 | $19.5K | 0.00% | −2,400−8.5% | Reduced |
| Tower Research Capital LLC (TRC) | 21,436 | $16.0K | 0.00% | +8,613+67.2% | Added |
| Russell Investments Group, Ltd. | 17,100 | $12.9K | 0.00% | 00.0% | Unchanged |
| Fisher Asset Management, LLC | 16,500 | $12.0K | 0.00% | 00.0% | Unchanged |
| StoneX Group Inc. | 15,000 | $11.3K | 0.00% | +15,000 | New |
| ACT Advisors, LLC. | 13,866 | $10.5K | 0.01% | +13,866 | New |
| Stratos Wealth Partners, LTD. | 10,489 | $7.93K | 0.00% | 00.0% | Unchanged |
| Pacifica Partners Inc. | 8,000 | $5.28K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 1,500 | $1.13K | 0.00% | 00.0% | Unchanged |
| Allworth Financial LP | 800 | $605 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 429 | $324 | 0.00% | +20+4.9% | Added |
| BNP Paribas Arbitrage, SA | 353 | $267 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 151 | $114 | 0.00% | +151 | New |
| JPMorgan Chase & Co | 210 | $0 | 0.00% | −33−13.6% | Reduced |
| Royal Bank of Canada | 15 | $0 | 0.00% | +15 | New |
| Knott David M Jr | 0 | $0 | 0.00% | −686,027−100.0% | Sold out |
| Monashee Investment Management LLC | 0 | $0 | 0.00% | −369,099−100.0% | Sold out |
| Bridgeway Capital Management, LLC | 0 | $0 | 0.00% | −140,000−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −41,819−100.0% | Sold out |
| Advisor Group Holdings, Inc. | 0 | $0 | 0.00% | −22,000−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −20,889−100.0% | Sold out |
| HSBC Holdings PLC | 0 | $0 | 0.00% | −17,001−100.0% | Sold out |
| Raymond James & Associates | 0 | $0 | 0.00% | −11,672−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −405−100.0% | Sold out |